baber/WOPTO huggingface dataset:
Patent AU-764403-B2 (AU)
Title: System for real-time monitor and response
Inventor: GRINTER RICHARD C
IPC: G06F17/40
Filed: 2000-01-25
Granted: 2003-08-21
Abstract: A data and object monitoring and response system comprising a three tier infrastructure for optimization of interoperability and task specific adaptability. The system gathers information from a plurality of distributed data gathering units and assimilates, processes, analyzes and distributes the gathered data within a common system with rule based data processing for coordinated response to the data. The data gathering units can be locally distributed or widely disbursed. The information gathered can be real-time collection of event data, historical data, systems monitoring, or other data. Regardless of the specific nature of the data, the system taught in the present invention, addresses a number of common problems associated with the collection, assimilation, processing of data. By dividing the system into a three tier interactive structure, the data can be gathered, evaluated and processed independently and efficiently and appropriate response can be effectively implemented. The processing tier, which includes the rules for analysis of the data, exists independent of the operator interface and data gathering tiers. A wide diversity of data collection equipment can be accommodated without modification of the operator interface or the processing tier. Processing rules can be modified without altering the collection and handling of data, and a commonality of data structure eliminates multiple polling of collected data sets.
Patent AU-607571-B2 (AU)
Title: Distributed load sharing
Inventor: HART JOHN HENRY
IPC: H04L12/28
Filed: 1989-01-06
Granted: 1991-03-07
Abstract: Methods and apparatus for exchanging frames between bridges distribute load sharing in a communications network. The communications network is of the kind in which bridges, and related stations and local LANs, e.g. Ethernet LANs and 802 LANs, can be linked by paths in a plurality of sub-networks and wherein the bridges are linked to support a Spanning Tree Protocol (STP) which elects one bridge as a root and then with respect to said root, computes and utilizes one and only one loop-free set of primary paths between all bridges. Remaining paths, i.e. paths other than said STP primary paths, between the bridges are examined as possible sub-network paths for a Distributed Load Sharing (DLS) configuration in which frames exchanged between certain stations can utilize more than the STP one set of primary paths. Certain ones of the remaining paths are selected as DLS paths under certain conditions and frames are routed over a selected DLS path only when those frames meet certain criteria.
Patent AU-685964-B2 (AU)
Title: Device for producing soap lather and use thereof
Inventor: EHRENSPERGER MARKUS
IPC: A45D27/10
Filed: 1995-07-17
Granted: 1998-01-29
Abstract: PCT No. PCT/CH95/00165 Sec. 371 Date Jan. 29, 1997 Sec. 102(e) Date Jan. 29, 1997 PCT Filed Jul. 17, 1995 PCT Pub. No. WO96/02178 PCT Pub. Date Feb. 1, 1996Soap lather dispensers are known which process soap solution and air via a flexible arrangement in a foaming unit to produce lather. These devices are either costly to manufacture or produce lather of unreliable and/or poor quality. A uniform lather quality can be ensured independently of the actuation path (P) by a metering pump (1) which operates synchronously with the air pump (12) and has no dead spaces. With special blower units, in particular by the incorporation of the foaming unit (18) in an air chamber (17), the lather quality is further improved. The device is suitable in particular for frequent use in public washrooms.
Patent AU-751995-B2 (AU)
Title: Visual prosthesis
Inventor: HUMAYUN MARK S
IPC: F16L19/02
Filed: 1999-03-11
Granted: 2002-09-05
Abstract: The prostheses comprises a camera converting images into electrical signals, which are modulated into RF carrier signals for wireless transmission from a coil (16) outside the eye (in e.g. an eyeglass lens) to as second coil (18) implanted behind the iris (48). This is connected to decoding circuitry (20) from where the signals are coupled to the retina (50) by an electrode array (22). An independent claim is also included for the following: The method of partially restoring vision to sufferers from phtotreceptor degenerative retinal conditions.
Patent AU-759901-B2 (AU)
Title: Repositioning device for bone fragments
Inventor: HEHLI MARKUS
IPC: A61B17/88
Filed: 2000-03-21
Granted: 2003-05-01
Abstract: The invention relates to a device for reducing bone fragments, especially at the pelvic bone or the tubular bone. The inventive device comprises A) a first clamping element (6) comprising a bow (2) with a front end piece (3) for placing against a bone fragment and a rod (24) that joins the bow (2) at the outside and at the rear end piece (4) thereof; B) a second longitudinal clamping element (7) comprising a longitudinal axis (10) as well as a front end (8) for placing against an additional bone fragment; C) a connecting element (14) for connecting the second clamping element (7) to the first clamping element (6) in such a way that the second clamping element (7) can be displaced in parallel in relation to the longitudinal axis (10) and relative to the first clamping element (6); a handle (5) and D) clamping means (35) by means of which the second clamping element (7) can be detachably fixed in relation to the first clamping element (6), whereby E) the front end piece (3) of the bow (2) and the second clamping element (7) are provided with bores (12; 13) parallel in relation to the longitudinal axis (10), whereby said bores can receive a guide wire and a Kirschner wire (23) respectively or a trocar.
Patent AU-619823-B2 (AU)
Title: Process for production of aromatic carbonate compound
Inventor: KISO YOSHIHISA
IPC: C07C68/06
Filed: 1989-04-17
Granted: 1992-02-06
Abstract: Disclosed is a process for producing an aromatic carbonate which comprises reacting a phenolic compound with a di-aliphatic carbonate or an aliphatic-aromatic carbonate in the presence of a catalyst. The catalyst is either SnO and/or a tin compound represented by the following formula <CHEM> wherein X and Y are identical or different and each represents OH, SCN, OR<1>, OCOR<1> or a halogen atom, R<1> represents an alkyl or aryl group, X and Y are not alkoxy groups at the same time, and R represents an alkyl or aryl group; or at least one compound of an element selected from the group consisting of Sc, Cr, Mo, W, Mn, Au, Ga, In, Bi, Te and lantanoids. The use of these specific catalysts enables the product to be obtained in high yields and selectivities and makes it easy to purify the product.
Patent AU-671974-B2 (AU)
Title: Carbamates and plant-protecting agents containing them
Inventor: MUELLER BERND
IPC: C07D213/30
Filed: 1993-01-18
Granted: 1996-09-19
Abstract: Carbamates of the formula I wherein B is a saturated or unsaturated heterocyclic group, and the other substituents are defined in the specification, and having crop protection properties.
Patent AU-618806-B2 (AU)
Title: Halogen-substituted phenoxybenzyl (thi)ol derivatives
Inventor: DORNHAGEN HORST DR
IPC: C07C41/00
Filed: 1989-05-03
Granted: 1992-01-09
Abstract: Pure dimethyl ether is obtained by passing the dehydration product from a dimethyl ether synthesis reactor into a distillation column in order to obtain pure dimethyl ether on specific trays of this column and removing the pure dimethyl ether and a fraction which contains impurities on specific trays of the same column, it being possible to use, in addition to the dehydration product, a scrubbing liquid and bases.
Patent AU-739486-B2 (AU)
Title: Automated method and apparatus for single sided hydration of soft contact lenses in package carriers
Inventor: CALVIN OLIN W
IPC: B65B25/00
Filed: 1997-08-13
Granted: 2001-10-11
Abstract: An automated means for hydrating and packaging a molded hydrophilic contact lens in one of the mold parts used to mold the lens is provided in which a first robotic assembly removes a plurality of contact lens molds from a production line carrier, each of the lens molds having a contact lens adhered therein. The first robotic assembly transports the molds to a first staging area where the lens molds are sandwiched between a lens mold carrier and a top chamber plate to form a first hydration carrier. The hydration carrier is then transported through a plurality of flushing or extraction stations wherein fresh deionized water is introduced into the hydration chambers at each hydration station to flush leachable substances from the hydration chamber. At each flushing station, fresh deionized water is introduced into the hydration chamber to remove previously extracted impurities and the products of hydrolysis. A final robotic dis-assembly device separates the top chamber plate and lens molds in the mold carrier plate, to provide fully hydrated lenses in a concave lens mold ready for transfer to inspection and packaging stations. Following inspection of the lens, the concave lens mold is dosed with saline and used to form part of the package used to distribute the lens.
Patent AU-689958-B2 (AU)
Title: Heat exchanger
Inventor: RAMM-SCHMIDT LEIF
IPC: F28F21/06
Filed: 1995-09-26
Granted: 1998-04-09
Abstract: PCT No. PCT/FI95/00525 Sec. 371 Date May 29, 1997 Sec. 102(e) Date May 29, 1997 PCT Filed Sep. 26, 1995 PCT Pub. No. WO96/09871 PCT Pub. Date Apr. 4, 1996The invention relates to a heat exchanger wherein the heating vapor is fed onto heat exchange surfaces of membrane material from a vapor distributor, the vapor distributor having parallel conduits for directing vapor over the entire width of the surfaces. According to the invention the vapor distributor is made up of two opposing wall elements which are fastened to each other by means of projections in one element and corresponding recesses in the other element. The upper end of the membrane constituting the heat exchange surface is locked between the projections and recesses that are fastened to each other. Thus, pleats are produced in the membrane as an expansion leeway for the vapor space delimited by the membrane. The heat exchange surfaces may be formed into bags, the ends of which are fastened between the interlinked wall elements in such a manner that the vapor conduits delimited by the elements will direct heating vapor to the inside of the bags and the liquid conduits will direct liquid to be evaporated onto the outer surfaces of the bags.
Patent AU-776470-B2 (AU)
Title: Device for injecting a product on a predetermined site of a moving object
Inventor: MIE PATRICK
IPC: B65B43/60
Filed: 2001-01-23
Granted: 2004-09-09
Abstract: A device for injecting a product towards a predetermined site of objects continuously moving along a given path while being spaced apart from one another by a specific step. The device (10) includes a series of injectors (26) borne by a mobile support (28) while being spaced apart on the support by a pitch corresponding to that of the objects, and the support (28) is driven in a reciprocating movement such that, during a forward phase of the movement, the injectors (26) move each opposite the predetermined site of one of the objects, and in the time interval of the reciprocating movement of the support is equal to the time interval between the passage of two consecutive objects in front of a common fixed point, multiplied by the number of injectors on the support.
Patent AU-608715-B2 (AU)
Title: Tarnish-resistant noble metal alloys for dentistry
Inventor: KROPP RUDOLF DR
IPC: C22C5/00
Filed: 1989-06-08
Granted: 1991-04-11
Abstract: The alloys, with or without plastic veneer, are low-cost and consist of 36-39% silver, 28-32.5% gold, 17-19.5% palladium, 0-0.1% iridium, 9.5-10.5% copper, 0.5-3.0% indium and 0.5-2.5% zinc, where the total of the contents of indium and zinc must not exceed 4%.
Patent AU-627189-B2 (AU)
Title: A security system
Inventor: MORGAN BARRY ALFRED
IPC: G08B15/02
Filed: 1989-06-13
Granted: 1992-08-20
Abstract: A security system for protecting the contents of a security container such as a safe or strong box (11) from attack comprises detector means (33, 48, 121) for detecting any attempt to move the container (11) or to enter it other than by authorised means, and the apparatus includes trigger means (118) fired in response to signals generated by the sensors (33, 48, 121) when such signals are identified by trigger control circuits (51, 52, 107, 130) as constituting an alarm event. Firing of the trigger (118) causes release of dye, smoke or other contaminants whereby to render the contents of the safe or strong box valueless and to mark the perpetrators of the crime for ease of subsequent identification.
Patent AU-617499-B2 (AU)
Title: Dna constructs and plants incorporating them
Inventor: ELY SUSAN
IPC: C12R1/07
Filed: 1989-08-02
Granted: 1991-11-28
Abstract: The gene promoter which drives expression of the chlorophyll antibody (CAB) protein in the green tissue of plants has been isolated and sequenced enabling use of the promoter, by recombinant DNA techniques, for green tissue specific expression of an exogenous gene by transformation of a plant with the a recombinant DNA in which the CAB promoter is fused to the exogenous gene. Particularly useful applications of the CAB promoter are in the expression of insecticidal toxins, such as a  delta -endotoxin of Bacillus thuringiensis, to provide protection of the plant from predation by insects which attack the green tissue, and in the expression of mRNA which is anti sense to mRNA expressed by an endogenous gene so as to suppress translation of the endogenous mRNA to protein.
Patent AU-783933-B2 (AU)
Title: Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-MTDC) and/or physiologically compatible salts for treating and/or preventing cancers
Inventor: SUSILO RUDY
IPC: A61P35/00
Filed: 2001-02-15
Granted: 2005-12-22
Abstract: Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid (2-MTDC) and/or its physiologically tolerable salts for the treatment and/or prevention of cancer.
Patent AU-703281-B2 (AU)
Title: Propargylethoxyamino nucleotides
Inventor: KHAN SHAHEER H
IPC: C12Q1/68
Filed: 1997-08-13
Granted: 1999-03-25
Abstract: Propargylethoxyamino nucleosides are disclosed having the structure wherein R<SUB>1 </SUB>and R<SUB>2 </SUB>are -H, lower alkyl, or label; B is a 7-deazapurine, purine, or pyrimidine nucleoside base; W<SUB>1 </SUB>is -H or -OH; W<SUB>2 </SUB>is -OH or a moiety which renders the nucleoside incapable of forming a phosphodiester bond at the 3'-position; and W<SUB>3 </SUB>is -PO<SUB>4</SUB>, -P<SUB>2</SUB>O<SUB>7</SUB>, -P<SUB>3</SUB>O<SUB>10</SUB>, phosphate analog, or -OH. Additionaly, a primer extension method is provided employing the above propargylethoxyamino nucleosides.
Patent AU-587977-B2 (AU)
Title: Biodegradable amphipathic copolymers
Inventor: CHURCHILL JEFFREY RICHARD
IPC: A61K9/22
Filed: 1985-05-30
Granted: 1989-09-07
Abstract: A pharmaceutically or veterinarily acceptable amphipathic, non-cross linked linear, branched or graft block copolymer, which has a minimum weight average molelcular-weight of 1000, in which the hydrophobic component is biodegradable or hydrolytically unstable under normal physiological conditions, and the hydrophilic component may or may not be biodegradable or hydrolytically unstable under such conditions, and which copolymer is self-dispersible in water; together with mixtures of such a copolymer and a drug, which may be water-soluble or water-insoluble, which mixtures are self-dispersible in water; and processes for the manufacture of such copolymers and such mixtures.
Patent AU-672009-B2 (AU)
Title: Process for producing a protective coating on metal walls subject to attack by hot gases, especially flue gases
Inventor: HAUSER BODO
IPC: C23C4/12
Filed: 1993-06-11
Granted: 1996-09-19
Abstract: A process for producing a protective coating on walls subject to attack by hot gases in a predetermined temperature range, which are made of metal and a predetermined basic material, in combustion plants, heat exchangers or similar installations, in which a powder of metallic, carbide, oxycarbide or silicide materials or mixtures thereof are applied to the metal walls using the plasma jet process. The invention proposes that: a) the surface of the wall is roughened; b) the basic material of the wall is activated; and c) immediately afterwards the powder is applied at room temperature and in atmospheric conditions by the plasma jet process; being d) the composition of the powder selected beforehand so that the stress as a function of the temperature in the unstressed state (at room temperature) found with the aid of the coefficients of heat expansion of the basic material and test-pieces for the transition region between the basic material and the applied coating produced from various powders gives tensile stresses of between 50 and 800 N/mm2 and preferably between 500 and 800 N/mm2, which is reduced to 0 or exhibits slight compression stresses in the predetermined temperature range.
Patent AU-779404-B2 (AU)
Title: Novel indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals
Inventor: THIEL STEFFEN
IPC: C07K14/47
Filed: 2000-05-10
Granted: 2005-01-20
Abstract: The present invention relates to the use of a composition comprising at least one mannan-binding lectin (MBL) subunit, or at least one mannan-binding lectin (MBL) oligomer comprising the at least one mannan-binding lectin (MBL) subunit, in the manufacture of a medicament for prophylaxis and/or treatment of infection. In particular the invention relates to prophylaxis and/or treatment of infection in an individual having an immunocompromised condition; and/or an individual being at risk of acquiring an immunocompromised condition resulting from a medical treatment. The present invention is particular relevant for prophylaxis and/or treatment of infection in individuals suffering from neutropenia, in particular as prophylaxis and/or treatment of infection in individuals receiving or going to receive chemotherapy or similar treatment. The individuals may be treated independent on their serum MBL level, and it has been shown that in particular individuals having a serum MBL level in the range of from 50 ng/ml serum to 500 ng/ml serum may benefit from the prophylaxis and/or treatment.
Patent AU-638954-B2 (AU)
Title: Products and methods for controlling the suppression of the neoplastic phenotype
IPC: A61K49/00
Filed: 1989-10-30
Granted: 1993-07-15
Abstract: A method for gene therapy for cancers wherein chromosomal location of an inactive or defective cancer suppressing gene is established, a replacement gene which is preferably cloned is then used to replace the inactive or defective cancer suppressing gene in the chromosome. In addition to its uses in therapy, the present invention provides a means for prophylactically treating individuals having a genetic predisposition to cancer and provides an animal model for testing for carcinogenicity of environmental substances.
Patent AU-772257-B2 (AU)
Title: Ammonium heteropolyacid catalyzed polymerization of olefins
Inventor: JOHNSON JOHN R
IPC: C08F4/22
Filed: 2000-05-10
Granted: 2004-04-22
Abstract: Calcined ammonium salts of phosphotungstic acid salts are used to polymerize C2-C30 alpha-olefins and derivatives thereof to form highly reactive products having a high content of terminal vinylidene groups and beta-isomers in resonance therewith.
Patent AU-734220-B2 (AU)
Title: Cloning and characterization of napsin, an aspartic protease
Inventor: KOELSCH GERALD
IPC: G01N33/573
Filed: 1997-11-20
Granted: 2001-06-07
Abstract: A previously unknown aspartic protease capable of cleavage of proteins by hydrolysis, referred to herein as "napsin", has been cloned from a human liver library. Two cDNA clones have been cloned, sequenced and expressed. These encode isozymes of the protease, referred to as "napsin A" and "napsin B". The gene has also be obtained and partially sequenced. A process for rapid purification of the enzyme using immobilized petpstatin has also been developed, and enzyme isolated from human kidney tissue. Polyclonal antibodies to the enzymes have been made which are also useful for isolation and detection of the enzyme. Similarities to other aspartic proteases, especially cathepsin D, establish the usefulness of the enzyme in diagnostic assays as well as as a protease. Either or both the amount or type of napsin expressed in a particular tissue can be determined using labelled antibodies or nucleotide probes to the napsin.
Patent AU-751965-B2 (AU)
Title: Superabsorbent polymers having anti-caking characteristics
Inventor: SUN FANG
IPC: C08L33/20
Filed: 1999-08-18
Granted: 2002-09-05
Abstract: A particulate material composition of superabsorbent polymer particles, wherein less than about 60% by weight of the superabsorbent polymer particles will pass through a U.S. Standard 50 mesh sieve. The composition has anti-caking properties and also reduced dusting. The composition can be produced by mixing the superabsorbent polymer particles with an inorganic powder, such as clay.
Patent AU-772303-B2 (AU)
Title: Methods of using and compositions comprising dopamine reuptake inhibitors
Inventor: JERUSSI THOMAS P
IPC: A61K45/06
Filed: 1999-08-23
Granted: 2004-04-22
Abstract: Methods are disclosed for the treatment and prevention of disorders and conditions including, but are not limited to, erectile dysfunction, affective disorders, weight gain, cerebral functional disorders, pain, obsessive-compulsive disorder, substance abuse, chronic disorders, anxiety, eating disorders, migraines, incontinence, depresson, attention deficit disorder, attention deficit disorder with hyperactivity, bipolar and manic conditions, dysthymic disorder, and cyclothymic disorder, senile dementia, Alzheimer's type dementia, memory loss, amnesia/amnestic syndrome, disturbance of consciousness, coma, lowering of attention, speech disorders, Parkinson's disease, Lennox syndrome, autism, epilepsy, hyperkinetic syndrome and schizophrenia. The methods comprise the administration of a dopamine reuptake inhibitor and optionally an additional pharmacologically active compound. Pharmaceutical compositions and dosage forms are also disclosed that comprise a dopamine reuptake inhibitor and optionally an additional pharmacologically active compound. Preferred dopamine reuptake inhibitors are racemic or optionally pure sibutramine metabolites, wherein the sibutramine metabolite is selected from the group consisting of (+)-desmethylsibutramine, (-)-desmethylsibutramine, (±)-desmethylsibutramine, (+)-didesmethylsibutramine, (-)-didesmethylsibutramine, and (±)-didesmethylsibutramine.